ArticleBritish journal of cancer2012

Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.

Y Kususda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.